Argenx Se ARGX
NASDAQ ARGX
$818.95 -27.32 (-3.23%)
As of: Oct 16, 2026 · 3:59 PM EDT

Argenx Se (ARGX) Non-Current Debt (2016 - 2017)

Updated

Analysis

Argenx Se (ARGX) Non-Current Debt (2016 - 2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 37.34 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 62.48 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 23.68 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 23.83 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 60.50 Bn
10 Argenx Se 50.23 Bn 34.19 Bn 1.37 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 14.95 Mn
Dec 31, 2016 12.89 Mn
API Access

Argenx Se Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=ARGX&period=max&api_key=YOUR_API_KEY